Compare CoImmune vs Opal Therapeutics
Customers evaluate the quality of CoImmune's products using the following success metrics.
Overview
CoImmune is 27 yrs old and is based in United States.
CoImmune, fka Argos Therapeutics, is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases. Using biological components from each patient, the company's immunotherapies employ the patient's dendritic cells to activate an immune response specific to the patient's disease.
Opal Therapeutics is based in Australia
Opal Therapeutics is an immunotherapy company focused on therapies for human immunodeficiency virus (HIV) and Hepatitis C (HCV), based on technology from the University of Melbourne.
Demo Video
Leadership
Jeffrey D Abbey (President)
Stephen Kent (Founder)
Funding
Investors
Korea Investment Partners, Dr. Lucio Rovati
UniSeed, Alloy Ventures
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because CoImmune has not claimed their profile.
Work for CoImmune? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for CoImmune?
Claim your profile now.
Information not available because Opal Therapeutics has not claimed their profile.
Work for Opal Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Opal Therapeutics?
Claim your profile now.